Complex Generics Portfolio

About torrent-pharmaceuticals

Torrent Pharmaceuticals is a mission-driven, revenue-generating leader in the global branded generics market, focused on improving patient access to high-quality, complex medicines. Its core strategy of therapeutic area specialization and geographic diversification has yielded market leadership in India, Brazil, and Germany, supported by a robust manufacturing and R&D infrastructure. The company is executing a growth strategy centered on expanding its portfolio of complex generics, biosimilars, and consumer healthcare brands while maintaining a strong commitment to sustainability and ESG principles.

About mankind-pharma

Mankind Pharma is a dominant Indian pharmaceutical player with a mission to deliver affordable and accessible healthcare across the nation. Founded in 1995, it has achieved market leadership through deep penetration of underserved rural and semi-urban markets, supported by a company-owned distribution infrastructure. Its strategy is built on a diversified business model spanning formulations, consumer healthcare, APIs, and agritech, backed by significant R&D capabilities and manufacturing scale. The company is publicly traded and is recognized for its operational excellence and commitment to serving 'Bharat'.

About alembic-pharmaceuticals

Alembic Pharmaceuticals' mission is to accelerate access to quality, affordable medicines globally through a vertically integrated model spanning API synthesis to finished dosage forms. The company has achieved significant scale, with over $250M in annual US frontend sales, a pipeline of 252 ANDA filings, and a strategic foray into proprietary drug discovery with three disclosed NCE candidates. Its strategy balances cash-generating generics businesses with disciplined R&D investments in complex generics and novel therapeutics to drive long-term, high-margin growth.

Therapeutic Areas